Headlands Research

Revenue and Accounts Receivable Specialist

Job Locations US-Remote | US-Remote
ID
2024-1770
Category
Accounting/Finance
Position Type
Regular Full Time

Overview

At Headlands Research, we are dedicaed to enhancing clinical trial delivery within our communities. We’re an exceptional family of next-generation clinical trial sites, integrating cutting edge technology and high-quality support services, and significantly expanding participant engagement Founded in 2018, our company operates clinical trial sites in the US and Canada with rapid plans for expansion.  

 

 

The Role

 

The Revenue and Accounts Receivable Specialist will work closely with site operations to approve billable expenses, manage Accounts Receivable, and be responsible for following up on final study budget balances. 

 

 

 

Responsibilities

  • Oversee financial and contractual performance on studies
  • Maintain strong relationship and work as liaison between clinical team and Sponsor/Contract Research Organization (CRO)
  • Verify and update study budgets
  • Invoice and apply payments from Sponsor/CRO
  • Reconcile study throughout
  • Conduct Month-End processes – revenue recognition and AR reporting
  • Prepare and follow up on Accounts Receivable Statements
  • Accountability for DSO and invoicing metrics
  • Perform financial analysis and reporting
  • Perform other duties as assigned

 

Qualifications

  • Bachelor’s Degree in Finance or Accounting required
  • Experience in Clinical Research (basic knowledge of medical terminology and working knowledge of drug development services) preferred
  • Understanding of the Clinical Trial Management System (CTMS) CRIO preferred
  • Effective communication skills (written/verbal)
  • Strong attention to detail and accuracy
  • Ability to interpret contract payment terms
  • Computer proficiency, including Microsoft products (especially Excel and Outlook)

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed